This page includes the latest FDA filings for Aimmune Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | AIMT | DUNS 057562771 |
Device Company | Device | Date |
|---|---|---|
| Aimmune Therapeutics, Inc., Seres Therapeutics, Inc. | Prescription Medication | 2025-03-27 |
| Aimmune Therapeutics, Inc. | Prescription Medication | 2025-01-24 |
| Aimmune Therapeutics, Inc., Seres Therapeutics, Inc. | Prescription Medication | 2024-07-13 |
| Aimmune Therapeutics, Inc. | Prescription Medication | 2024-05-22 |
| Aimmune Therapeutics, Inc. | Prescription Medication | 2024-03-15 |
| Aimmune Therapeutics, Inc. | Prescription Medication | 2023-11-10 |
| Aimmune Therapeutics, Inc. | Prescription Medication | 2023-10-21 |
| Aimmune Therapeutics, Inc., Seres Therapeutics, Inc. | Prescription Medication | 2023-05-05 |
| Aimmune Therapeutics, Inc. | Prescription Medication | 2021-11-10 |
| Aimmune Therapeutics, Inc. | Prescription Medication | 2021-01-01 |
| NCAGE Code | 8H6R2 | AIMMUNE THERAPEUTICS, INC. |
| CAGE Code | 8H6R2 | AIMMUNE THERAPEUTICS, INC. |
| S.A.M. Registration | 8H6R2 [57562771] | AIMMUNE THERAPEUTICS, INC. |
| SEC | 0001631650 | Aimmune Therapeutics, Inc. of DELAWARE |